Greater inhibition of female rat binge alcohol intake by adrenergic receptor blockers using a novel Two-Shot rat binge drinking model

• Published in: Scientific reports 2024-06, Vol.14 (1), p.14029-11
• Main Authors: De Oliveira Sergio, Thatiane, Jane Smith, Rebecca, Wean, Sarah E., Engleman, Eric A., Hopf, Frederic W.
• Format: Article
• Language: English
• Subjects: 631/154/436; 631/378; Adrenergic Antagonists - pharmacology; Adrenergic receptors; Alcohol; Alcohol Drinking; Alcohol use; Alcoholic beverages; Alcohols; Animal models; Animals; Binge drinking; Binge Drinking - drug therapy; Blood levels; Dietary restrictions; Disease Models, Animal; Drinking behavior; Ethanol; Female; Females; Gender differences; Humanities and Social Sciences; Male; multidisciplinary; Naltrexone; Naltrexone - pharmacology; Prazosin; Propranolol; Propranolol - pharmacology; Rats; Rats, Wistar; Science; Science (multidisciplinary); Sex differences; Sex Factors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-64565-9

Binge drinking (BD) contributes strongly to the harms of alcohol use disorder. Most rodent models do not result in binge-level blood alcohol concentrations (BACs), and to better understand individual and sex differences in neurobiological mechanisms related to BD, the use of outbred rat strains would be valuable. Here, we developed a novel BD model where after 3+ months of intermittent access to 20% alcohol Wistar rats drank, twice a week, with two 5-min intake (what we called Two-shot) separated by a 10-min break. Our findings showed during Two-Shot that most animals reached ≥ 80 mg% BAC levels (when briefly food-restricted). However, when increasing alcohol concentrations from 20 to 30%, 40%, or 50%, rats titrated to similar intake levels, suggesting rapid sensing of alcohol effects even when front-loading. Two-Shot drinking was reduced in both sexes by naltrexone (1 mg/kg), validating intake suppression by a clinical therapeutic agent for human problem drinking. Further, both propranolol (β-adrenergic receptor antagonist) and prazosin (α1-adrenergic receptor antagonist) reduced female but not male BD at the lower dose. Thus, our results provide a novel model for BD in outbred rats and suggest that female binging is more sensitive to adrenergic modulation than males, perhaps providing a novel sex-related therapy.